eli-lilly-glp-1-pillen-offensive - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,058 +0.17%

DJIA 48,750 +0.21%

Nasdaq 26,368 +0.18%

DAX 24,272 +0.61%

Gold $4,196 +0.16%

Oil $89.77 +0.12%

BTC $75,121 -0.12%

VIX 20.43 -0.11%

EUR/USD 1.1785 -0.02%

ETH $2,341 -0.34%

S&P 500 7,058 +0.17%

DJIA 48,750 +0.21%

Nasdaq 26,368 +0.18%

DAX 24,272 +0.61%

Gold $4,196 +0.16%

Oil $89.77 +0.12%

BTC $75,121 -0.12%

VIX 20.43 -0.11%

EUR/USD 1.1785 -0.02%

ETH $2,341 -0.34%

eli-lilly-glp-1-pillen-offensive

Eli Lilly GLP-1 pill concept in a modern lab symbolizing new obesity drug Foundayo

Pharma & Healthcare·Stocks·USA

Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?

By Maik Kemper • Apr 13, 2026

Eli Lilly GLP-1 pill concept in a modern lab symbolizing new obesity drug Foundayo

Pharma & Healthcare·Stocks·USA

Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?

By Maik Kemper • Apr 13, 2026

Can the new Eli Lilly GLP-1 pill Foundayo justify the stock’s rich valuation and extend its obesity drug dominance? Maik Kemper Editor in Chief Conclusion…